Why Infectious Disease Physicians Get Sued: The Delayed Antibiotic, the Missed Endocarditis, and the Septic Cascade

By John Mahoney · June 2026 · 8 min read

Infectious disease is a consultant's specialty, and that shapes its liability in a way attorneys often miss. The ID physician rarely controls the patient — they advise, recommend cultures, suggest antibiotics, and flag the need for drainage or device removal, while a primary or surgical team decides what to do with that advice. The result is a malpractice profile dominated not by procedures but by time and communication: the delayed recognition of a life-threatening infection, the wrong empiric antibiotic given while the patient deteriorated, and the source-control recommendation that was made too softly or not at all. The injuries are catastrophic — sepsis, amputation, neurologic devastation, death — so even an uncommon claim carries high severity. This guide explains where infectious disease liability actually lives, the cannot-miss diagnoses behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The patterns below draw on closed-claims literature, sepsis and stewardship guidelines, and commonly reported allegation types that span different eras and definitions; treat them as directional, verify against the controlling jurisdiction, and value any individual case on its own record.

The Frequency-and-Severity Reality

Infectious disease is not among the highest-frequency specialties for claims volume — the ID physician is usually a consultant rather than the captain of the ship, and shared responsibility across a treating team tends to dilute the share of suits that name ID alone. But that low frequency hides a high severity. The infections that generate claims are the ones that kill or maim on a clock: sepsis and septic shock, infective endocarditis, bacterial meningitis, necrotizing fasciitis, spinal epidural abscess. When the diagnosis is delayed, the outcome is commonly death or permanent disability, and the damages follow accordingly.

The defining feature of this specialty's litigation is time dependence. In sepsis and septic shock, survival is widely reported to fall with each hour that effective antibiotics and source control are delayed, which makes the causation chain unusually concrete: a plaintiff can argue, hour by hour, that earlier action carried a materially better prognosis. That same time stamp is the defense's best friend when the record shows prompt cultures, prompt empiric coverage, and prompt escalation. Two valuation realities therefore live inside this specialty — a diagnostic-delay model built on the clock, and a therapeutic-and-monitoring model built on antibiotic choice and toxicity — and you must route every intake to the right one immediately.

The Dominant Allegation Types

Infectious disease claims cluster into a diagnostic-delay group and a therapeutic-management group, with a consultant-communication thread running through both:

• Delayed or missed diagnosis of a life-threatening infection — the highest-severity category, covering failure to recognize sepsis or septic shock, infective endocarditis, bacterial meningitis, necrotizing fasciitis, spinal epidural abscess, and osteomyelitis early enough to change the outcome.
• Improper antibiotic selection or stewardship — inadequate or wrong empiric therapy, failure to cover the likely pathogen, failure to obtain cultures before starting antibiotics, and failure to de-escalate or adjust for resistance once data returned.
• Antimicrobial toxicity and monitoring failure — renal injury from vancomycin or aminoglycosides, dangerous drug interactions, and antibiotic-associated Clostridioides difficile colitis from inadequately stewarded therapy.
• Failure to recognize and communicate the need for source control — not escalating the recommendation to drain an abscess, remove an infected line or device, or debride dead tissue, and not making that recommendation clearly to the surgical or primary team.
• Missed opportunistic infection in the immunocompromised or HIV patient — failure to consider and work up an atypical or opportunistic pathogen, often compounded by thin documentation of the reasoning.

The structural point: by injury severity, the diagnostic-delay claims dominate, but the therapeutic-management claims are where the ID physician's own conduct is most directly in the frame. Any intake should be triaged first on which side of that line it sits, because the merit analysis, the experts, and the causation theory are entirely different.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive infectious disease litigation are:

• Sepsis and septic shock — delayed recognition or delayed treatment. This is the highest-volume, highest-severity exposure. The recurring failure is a patient with a rising lactate, hypotension, or organ dysfunction who did not receive timely cultures, fluids, and broad empiric antibiotics, with each hour of delay tightening the causation chain.
• Infective endocarditis — missed or misattributed. Persistent bacteremia, a new murmur, or embolic phenomena that were not pursued with blood cultures and echocardiography, allowing valve destruction, stroke, or septic emboli.
• Bacterial meningitis — delayed lumbar puncture and antibiotics. A short therapeutic window in which delay produces death or permanent neurologic injury; failure to start empiric coverage before imaging or LP is a classic allegation.
• Necrotizing fasciitis — mistaken for cellulitis. "Pain out of proportion," rapid progression, and systemic toxicity that were not escalated to urgent surgical debridement — a source-control failure with limb or life at stake.
• Spinal epidural abscess and osteomyelitis — the classic delayed diagnosis. Back pain with fever and neurologic signs that was not imaged promptly, producing paralysis; one of the most-litigated infection patterns because the deficit is permanent and the delay is visible in the chart.

For the diagnostic side, the single most actionable screening question is the clock question: when did the abnormal signal first appear in the record — the positive culture, the rising lactate, the neurologic change — and how long until effective antibiotics and source control followed? For the therapeutic side, the decisive question is whether the empiric regimen covered the likely pathogen and whether cultures were drawn before antibiotics were started, because both are visible in the record and both anchor the standard-of-care fight.

The Contributing Factors That Drive Payouts

Across infectious disease claims, the recurring contributing factors are:

• Clinical judgment and diagnostic timing — the costliest factor: failure to recognize sepsis, endocarditis, meningitis, or a deep-tissue infection early enough, where every hour of delay both worsens the outcome and strengthens the plaintiff's causation chain.
• Antibiotic selection and stewardship — wrong or inadequate empiric coverage, cultures not drawn before antibiotics, failure to broaden when the patient is deteriorating or to de-escalate and adjust for resistance when data returns; each is a discrete, chart-visible standard-of-care decision.
• Source-control recognition and escalation — failure to identify that drainage, debridement, or device removal was needed, and — the distinctively ID failure — failure to communicate that recommendation forcefully and clearly to the surgical or primary team.
• Antimicrobial monitoring and toxicity — inadequate level monitoring or dose adjustment for vancomycin or aminoglycosides leading to renal injury, missed drug interactions, and C. difficile colitis from over-broad therapy.
• Documentation of the consultant's reasoning — thin notes that fail to record the differential considered, the recommendation made, and the rationale — especially in immunocompromised and HIV patients — which weaken the defense even when the clinical judgment was reasonable.

Two of these are infectious-disease-specific levers. The first is the consultant-communication record: because the ID physician usually advises rather than orders, the line between a defensible file and a paid claim is often whether the chart shows a clear, escalated recommendation — "needs urgent surgical drainage," "remove the line now" — rather than a buried note that the treating team could plausibly have missed. The second is the timestamp ledger: in a sepsis or epidural-abscess case, the case is built or defended on the documented interval between the first abnormal signal and effective action. Documentation rarely creates liability here, but it consistently decides whether a claim is paid.

Strong Case vs. Weak Case in Infectious Disease Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes an infectious disease case strong (plaintiff) / dangerous (defense)

• A documented abnormal signal — positive blood culture, rising lactate, new neurologic deficit, "pain out of proportion" — followed by a long, unexplained interval before effective antibiotics or source control, anchoring a concrete hour-by-hour causation chain.
• Empiric therapy that plainly failed to cover the likely pathogen, or antibiotics started without any cultures drawn, leaving the regimen indefensible once the organism was known.
• A clear need for drainage, debridement, or device removal that the record shows was never recommended, or was recommended so passively that the treating team did not act.
• Renal injury or C. difficile colitis with no documented level monitoring, dose adjustment, or stewardship review — a clean toxicity-and-monitoring failure.

What makes an infectious disease case weak (plaintiff) / defensible (defense)

• A record showing prompt cultures, prompt broad empiric coverage appropriate to the presentation, and timely escalation, with the interval between signal and action measured in the right units — the clock on the defense's side.
• A clearly documented source-control recommendation that the treating or surgical team declined or delayed, shifting responsibility off the consultant.
• An atypical or fastidious organism, or a presentation that genuinely mimicked a benign process, where reasonable physicians would not have diagnosed sooner — framing the outcome as the disease, not negligence.
• Documented monitoring, dose adjustment, and de-escalation for antibiotic toxicity, plus a recorded differential and rationale in the consult note — the reasoning visible on the page.

Infectious disease rewards a fast triage on two axes. On the diagnostic side, the case lives or dies on the timestamp ledger and the hour-by-hour loss-of-chance chain for the sepsis, endocarditis, meningitis, or epidural abscess. On the therapeutic side, it turns on the empiric regimen, the culture timing, the toxicity monitoring, and — uniquely — whether the consultant's source-control recommendation was made clearly and escalated. Whichever side you are on, grading the file means matching the right model to the right claim and pressure-testing the expert who will carry it.

Bottom Line

Infectious disease physicians are sued less often than the proceduralists, but when they are, the injuries are among the most catastrophic in medicine and the causation chain is among the most concrete, because it runs on a clock. The cannot-miss facts are the delayed sepsis recognition, the missed endocarditis or meningitis, the necrotizing infection mistaken for cellulitis, the spinal epidural abscess left to progress to paralysis, the empiric antibiotic that never covered the pathogen, and the source-control recommendation that was needed but never clearly made. Whether you are screening these cases for the plaintiff or defending them, triage first to the right model — diagnostic delay or therapeutic management — and grade the file on the timestamp ledger, the consultant-communication record, and the documented antibiotic and monitoring decisions, not on the devastating outcome alone.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →